IL-6 derived from M2 type macrophages activates the Janus kinase 2/signal transducer activator of the transcription 3 pathway, promoting angiogenesis and inflammation in tumor tissues and enhancing the invasion, proliferation, and survival of cancer cells [6, 8, 30]. Here, IL6 is linked to cancer.